| Literature DB >> 20553998 |
Rongjie Yu1, Juan Li, Jingjing Wang, Xiaofei Liu, Lin Huang, Yong Ding, Jiansu Chen.
Abstract
PAC1 is a pituitary adenylate cyclase-activating polypeptide (PACAP) preferring receptor, which is abundant in the central and peripheral nervous systems. PAC1 belongs to the class B family of G protein-coupled receptors (GPCRs). The N-terminal first extracellular (EC1) domain of PAC1 is responsible for ligand recognition and binding. In this study, the recombinant EC1 domain of the PAC1 normal (N) form (amino acids 21-155) with 6His tag at the C-terminus (named PAC1-EC1(N)) was first expressed in an Escherichia coli strain and purified by an Ni-NTA affinity column. About 6-8mg of recombinant PAC1-EC1(N) protein with purity above 95% was produced from 1L of bacterial culture. Mass spectrum and western blot were used to identify the recombinant PAC1-EC1(N). Intrinsic tryptophan fluorescence (ITF) assays showed that the purified PAC1-EC1(N) protein was able to recognize and bind to the PAC1 selective agonist maxadilan, the antagonist M65 and vasoactive intestinal polypeptide (VIP). Maxadilan and M65 had higher affinities for PAC1-EC1(N) than VIP. The results of MTT assays showed that PAC1-EC1(N) stimulated the viability of PAC-CHO cells but blocked the effects of maxadilan on the proliferation of CHO cells expressing PAC1 (PAC1-CHO), indicating that the functional soluble PAC1-EC1(N) may act as a regulator for the activation of PAC1. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20553998 DOI: 10.1016/j.neulet.2010.06.007
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046